Rothschild Investment LLC’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53K Buy
147
+1
+0.7% +$25 ﹤0.01% 2332
2026
Q1
$3.15K Sell
146
-3
-2% -$65 ﹤0.01% 2315
2025
Q4
$3.55K Buy
149
+9
+6% +$184 ﹤0.01% 2066
2025
Q3
$1.9K Sell
140
-10
-7% -$104 ﹤0.01% 2259
2025
Q2
$1.22K Buy
150
+105
+233% +$897 ﹤0.01% 2360
2025
Q1
$353 Sell
45
-10
-18% -$116 ﹤0.01% 2728
2024
Q4
$819 Sell
55
-25
-31% -$408 ﹤0.01% 2337
2024
Q3
$1.22K Buy
80
+50
+167% +$788 ﹤0.01% 2018
2024
Q2
$457 Buy
30
+20
+200% +$323 ﹤0.01% 2076
2024
Q1
$189 Buy
+10
New +$173 ﹤0.01% 1767

Other funds holding RCUS

Rothschild Investment LLC's RCUS Position: Q2 2026 in Review

Rothschild Investment LLC increased its Arcus Biosciences (RCUS) stake by 0.68% in Q2 2026, buying an estimated $25 and bringing the position to 147 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

Rothschild Investment LLC first reported a position in RCUS in Q1 2024 and has held it in 10 quarters since. 72 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Rothschild Investment LLC held 147 shares of Arcus Biosciences worth $4.53K as of Q2 2026.
  • Rothschild Investment LLC bought 1 Arcus Biosciences share in Q2 2026, an estimated $25.
  • Arcus Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2332 holding.
  • Rothschild Investment LLC first reported a position in Arcus Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 72 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.